Assessing mental health disorders in Hong Kong using a new recall method

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study utilizes the World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) to evaluate the prevalence of major depressive disorders and suicidal ideation among residents in Hong Kong. To improve the accuracy of retrospective reporting, the study incorporates a life history calendar (LHC) that helps participants recall significant life events. By enhancing the CIDI-5 with the LHC, the study aims to provide a more reliable assessment of lifetime mental health issues. Participants will be randomly selected from a census list and must meet specific eligibility criteria.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All household members aged 25 years old and over are randomly sampled from the Census and Statistics Department List of Quarters
* Live in the address sampled from the Census and Statistics Department List of Quarters
* Reside in Hong Kong for at least six months in the past year
* Able to read and communicate in Chinese or English
* Without linguistic or cognitive difficulties

Exclusion Criteria:

* Domestic workers

Where it's running

• The University of Hong Kong
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Michael Y. Ni, MD — The University of Hong Kong
• Study coordinator: Yoona Kim, PhD
• Email: yoonak@hku.hk
• Phone: 852+39179109

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CIDI 5.0 validation against SCID-5 for lifetime mental disorders in Hong Kong adults

  This study tests whether the CIDI 5.0 interview can reliably identify lifetime mental disorders in adults in Hong Kong by comparing it with the SCID-5 diagnostic interview.

  Recruiting The University of Hong Kong · Hong Kong · NCT07604753

• Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy

  This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.

  Recruiting Phase 2/3 Coatesville VA Medical Center · Coatesville, Pennsylvania · NCT07756723

• Blended ERITA for Teens Who Self-Injure

  A blended, youth-focused therapy test combines in-person sessions with digital tools to help teens who have recently self-injured see if this approach improves emotion regulation and daily functioning.

  Recruiting Karolinska Institutet · Stockholm · NCT07755774

• TNX-102 SL taken at night for major depressive disorder

  A nighttime dose of TNX-102 SL is being tested to see if it helps adults with moderate to severe major depressive disorder compared to a placebo.

  Recruiting at 26 sites Phase 2 Tonix Pharmaceuticals, Inc. · Phoenix, Arizona and 26 other locations · NCT07621237

• How urban stress patterns relate to mental illness in adults

  This study tests whether real-time environmental stress in cities is linked to depression, anxiety, or alcohol use disorders in adults 18–60 who wear a wrist sensor and use a study app.

  Recruiting at 3 sites Huashan Hospital · Beijing and 2 other locations · NCT07571226

• Ketamine with DBT for suicidality in adults with treatment-resistant depression or bipolar disorder and BPD

  This study tests whether four ketamine infusions plus Dialectical Behavioural Therapy can more quickly reduce suicidal thoughts in adults with Borderline Personality Disorder and treatment-resistant depression or bipolar disorder.

  Recruiting Phase 2 University Health Network, Toronto · Toronto, Ontario · NCT07569198

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.